Trademark: 97038901
Status Date
Monday, February 26, 2024
Filing Date
Wednesday, September 22, 2021
Published for Opposition
Tuesday, January 4, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Feb 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 26, 2024
Sou Extension 4 Granted
Feb 26, 2024
Sou Extension 4 Filed
Feb 26, 2024
Sou Teas Extension Received
Aug 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2023
Sou Extension 3 Granted
Aug 22, 2023
Sou Extension 3 Filed
Aug 22, 2023
Sou Teas Extension Received
Feb 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2023
Sou Extension 2 Granted
Feb 23, 2023
Sou Extension 2 Filed
Feb 23, 2023
Sou Teas Extension Received
Aug 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2022
Sou Extension 1 Granted
Aug 12, 2022
Sou Extension 1 Filed
Aug 12, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Nov 29, 2021
Approved For Pub - Principal Register
Nov 23, 2021
Assigned To Examiner
Oct 25, 2021
New Application Office Supplied Data Entered
Sep 25, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24